INVO Fertility, Inc. (IVF) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by INVO Fertility, Inc. on June 1, 2026. The filing addresses a non-reliance on previously issued unaudited consolidated financial statements for the quarters ended March 31, 2025, June 30, 2025, and September 30, 2025 (the "Affected Periods"). The errors stem from an internal review regarding technical accounting treatments.
Key Financial Metrics
The filing does not provide specific updated numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The company explicitly states that the identified errors did not impact revenue or loss from operations. The impact is limited to assets, liabilities, equity, other income (expense), and net income (loss).
Material Changes and Restatement Details
The Audit Committee concluded that the previously issued 10-Q filings for the Affected Periods should no longer be relied upon due to the following accounting errors:
- Incorrect classification of Series C-1 Preferred Stock (Q1 2025) and Series C-2 Preferred Stock (Q2 2025), which should have been classified as mezzanine equity.
- Incorrect treatment of a convertible debenture with an embedded derivative that required bifurcation.
- Incorrect recognition of a gain on settlement and liability reduction related to a binding term sheet in Q2 2025.
- Incorrect equity classification of common stock purchase warrants issued in Q2 2025, which should have been classified as a liability.
- Incorrect accounting for a promissory note amendment in Q3 2025, which should have been treated as a debt extinguishment.
Outlook, Management Commentary, and Risks
Management and the Audit Committee have discussed these matters with the independent registered public accounting firm, WithumSmith+Brown, PC. The company states that the errors have not resulted in any change to the business plan or operations. The restatement of affected line items will be presented in the forthcoming Annual Report on Form 10-K for the year ended December 31, 2025. The previously issued 10-Qs will not be amended, but historical amounts in future filings will be recast.
Investor Verification Checklist
- Verify the upcoming Form 10-K for the year ended December 31, 2025, to review the restated financial figures.
- Monitor future 10-Q filings for recast historical data consistent with the restatement.
- Review the specific impact on the balance sheet (assets, liabilities, equity) and net income once the 10-K is filed.
- Confirm that the company's liquidity position remains stable despite the reclassification of debt and equity instruments.